EE200300495A - 3,7-diasabitsüklo[3.3.1]preparaadid, nende valmistamise meetod ja nimetatud preparaatide kasutaminesüdame arütmiate profülaktikas või ravis - Google Patents
3,7-diasabitsüklo[3.3.1]preparaadid, nende valmistamise meetod ja nimetatud preparaatide kasutaminesüdame arütmiate profülaktikas või ravisInfo
- Publication number
- EE200300495A EE200300495A EEP200300495A EEP200300495A EE200300495A EE 200300495 A EE200300495 A EE 200300495A EE P200300495 A EEP200300495 A EE P200300495A EE P200300495 A EEP200300495 A EE P200300495A EE 200300495 A EE200300495 A EE 200300495A
- Authority
- EE
- Estonia
- Prior art keywords
- diazabicyclo
- prophylaxis
- preparations
- preparation
- treatment
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/08—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5386—1,4-Oxazines, e.g. morpholine spiro-condensed or forming part of bridged ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/40—Cyclodextrins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0101329A SE0101329D0 (sv) | 2001-04-12 | 2001-04-12 | Pharmaceutical formulation |
| PCT/SE2002/000726 WO2002083689A1 (en) | 2001-04-12 | 2002-04-12 | 3,7-diazabicyclo [3.3.1] formulations as anti-arrythmic compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EE200300495A true EE200300495A (et) | 2003-12-15 |
Family
ID=20283785
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EEP200300495A EE200300495A (et) | 2001-04-12 | 2002-04-12 | 3,7-diasabitsüklo[3.3.1]preparaadid, nende valmistamise meetod ja nimetatud preparaatide kasutaminesüdame arütmiate profülaktikas või ravis |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US20050037067A1 (et) |
| EP (1) | EP1389212B1 (et) |
| JP (1) | JP2005500262A (et) |
| KR (1) | KR20030088498A (et) |
| CN (1) | CN1514839A (et) |
| AR (1) | AR035806A1 (et) |
| AT (1) | ATE332902T1 (et) |
| BG (1) | BG108234A (et) |
| BR (1) | BR0208828A (et) |
| CA (1) | CA2443473A1 (et) |
| CZ (1) | CZ20032774A3 (et) |
| DE (1) | DE60213084T2 (et) |
| EE (1) | EE200300495A (et) |
| HU (1) | HUP0303486A3 (et) |
| IL (1) | IL158033A0 (et) |
| IS (1) | IS6989A (et) |
| MX (1) | MXPA03009209A (et) |
| NO (1) | NO20034529L (et) |
| NZ (1) | NZ528561A (et) |
| PL (1) | PL366629A1 (et) |
| RU (1) | RU2003129230A (et) |
| SE (1) | SE0101329D0 (et) |
| SK (1) | SK12562003A3 (et) |
| TW (1) | TWI257391B (et) |
| WO (1) | WO2002083689A1 (et) |
| ZA (1) | ZA200307756B (et) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI259836B (en) * | 2001-04-12 | 2006-08-11 | Astrazeneca Ab | Modified release formulation suitable for antiarrhythmic compounds |
| US8158152B2 (en) * | 2005-11-18 | 2012-04-17 | Scidose Llc | Lyophilization process and products obtained thereby |
| GB0523810D0 (en) * | 2005-11-23 | 2006-01-04 | Astrazeneca Ab | Pharmaceutical compositions |
| CN101330919B (zh) * | 2005-12-20 | 2012-12-05 | 力奇制药公司 | 包含(e)-7-[4-(4-氟苯基)-6-异丙基-2-[甲基(甲磺酰基)氨基]嘧啶-5-基]-(3r,5s)-3,5-二羟基庚-6-烯酸的药物组合物 |
| US20080085303A1 (en) * | 2006-10-10 | 2008-04-10 | Penwest Pharmaceuticals Co. | Robust sustained release formulations of oxymorphone and methods of use thereof |
| CA2644179C (en) * | 2007-11-21 | 2018-09-25 | Pharmascience Inc. | Novel pharmaceutical composition comprising a disintegration matrix |
| DE102008047910A1 (de) | 2008-09-19 | 2010-03-25 | Molkerei Meggle Wasserburg Gmbh & Co. Kg | Tablettierhilfsstoff auf Laktose- und Cellulosebasis |
| US9408835B2 (en) * | 2013-03-29 | 2016-08-09 | Astellas Pharma Inc. | Pharmaceutical composition for oral administration |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3732094A1 (de) * | 1987-09-24 | 1989-04-06 | Basf Ag | Bispidinderivate als klasse iii-antiarrhythmika |
| US5110933A (en) * | 1989-11-13 | 1992-05-05 | Board Of Regents Of Oklahoma State University | Salts of 3-azabicyclo[3.3.1]nonanes as antiarrhythmic agents, and precursors thereof |
| DE4402933A1 (de) * | 1994-02-01 | 1995-08-03 | Kali Chemie Pharma Gmbh | Neue 3-Benzoyl-3,7-diazabicyclo[3,3,1] nonan-Verbindungen enthaltende Arzneimittel |
| SE9704709D0 (sv) * | 1997-12-17 | 1997-12-17 | Astra Ab | Pharmaceutically active compounds |
| JP2002541249A (ja) * | 1999-04-09 | 2002-12-03 | アストラゼネカ・アクチエボラーグ | アダマンタン誘導体 |
| SE9903759D0 (sv) * | 1999-10-18 | 1999-10-18 | Astra Ab | Pharmaceutically active compounds |
| US6500457B1 (en) * | 2000-08-14 | 2002-12-31 | Peirce Management, Llc | Oral pharmaceutical dosage forms for pulsatile delivery of an antiarrhythmic agent |
-
2001
- 2001-04-12 SE SE0101329A patent/SE0101329D0/xx unknown
-
2002
- 2002-04-01 TW TW091106495A patent/TWI257391B/zh not_active IP Right Cessation
- 2002-04-02 AR ARP020101187A patent/AR035806A1/es not_active Application Discontinuation
- 2002-04-12 MX MXPA03009209A patent/MXPA03009209A/es not_active Application Discontinuation
- 2002-04-12 DE DE60213084T patent/DE60213084T2/de not_active Expired - Fee Related
- 2002-04-12 IL IL15803302A patent/IL158033A0/xx unknown
- 2002-04-12 WO PCT/SE2002/000726 patent/WO2002083689A1/en not_active Application Discontinuation
- 2002-04-12 CZ CZ20032774A patent/CZ20032774A3/cs unknown
- 2002-04-12 US US10/474,584 patent/US20050037067A1/en not_active Abandoned
- 2002-04-12 EE EEP200300495A patent/EE200300495A/et unknown
- 2002-04-12 PL PL02366629A patent/PL366629A1/xx not_active Application Discontinuation
- 2002-04-12 CN CNA028116364A patent/CN1514839A/zh active Pending
- 2002-04-12 CA CA002443473A patent/CA2443473A1/en not_active Abandoned
- 2002-04-12 KR KR10-2003-7013299A patent/KR20030088498A/ko not_active Application Discontinuation
- 2002-04-12 NZ NZ528561A patent/NZ528561A/en unknown
- 2002-04-12 EP EP02723011A patent/EP1389212B1/en not_active Expired - Lifetime
- 2002-04-12 RU RU2003129230/15A patent/RU2003129230A/ru not_active Application Discontinuation
- 2002-04-12 AT AT02723011T patent/ATE332902T1/de not_active IP Right Cessation
- 2002-04-12 BR BR0208828-2A patent/BR0208828A/pt not_active IP Right Cessation
- 2002-04-12 SK SK1256-2003A patent/SK12562003A3/sk unknown
- 2002-04-12 HU HU0303486A patent/HUP0303486A3/hu unknown
- 2002-04-12 JP JP2002581444A patent/JP2005500262A/ja not_active Withdrawn
-
2003
- 2003-10-03 ZA ZA200307756A patent/ZA200307756B/en unknown
- 2003-10-06 BG BG108234A patent/BG108234A/bg unknown
- 2003-10-09 NO NO20034529A patent/NO20034529L/no not_active Application Discontinuation
- 2003-10-10 IS IS6989A patent/IS6989A/is unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CZ20032774A3 (cs) | 2004-01-14 |
| NO20034529D0 (no) | 2003-10-09 |
| NO20034529L (no) | 2003-12-08 |
| SE0101329D0 (sv) | 2001-04-12 |
| IL158033A0 (en) | 2004-03-28 |
| TWI257391B (en) | 2006-07-01 |
| AR035806A1 (es) | 2004-07-14 |
| HUP0303486A2 (hu) | 2004-01-28 |
| KR20030088498A (ko) | 2003-11-19 |
| EP1389212A1 (en) | 2004-02-18 |
| CN1514839A (zh) | 2004-07-21 |
| DE60213084D1 (de) | 2006-08-24 |
| BR0208828A (pt) | 2004-03-09 |
| CA2443473A1 (en) | 2002-10-24 |
| JP2005500262A (ja) | 2005-01-06 |
| MXPA03009209A (es) | 2004-01-29 |
| HUP0303486A3 (en) | 2005-04-28 |
| ZA200307756B (en) | 2005-01-03 |
| NZ528561A (en) | 2005-03-24 |
| US20050037067A1 (en) | 2005-02-17 |
| DE60213084T2 (de) | 2007-01-11 |
| IS6989A (is) | 2003-10-10 |
| WO2002083689A1 (en) | 2002-10-24 |
| BG108234A (bg) | 2005-04-30 |
| SK12562003A3 (sk) | 2004-03-02 |
| ATE332902T1 (de) | 2006-08-15 |
| PL366629A1 (en) | 2005-02-07 |
| EP1389212B1 (en) | 2006-07-12 |
| RU2003129230A (ru) | 2005-04-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EE04854B1 (et) | Oksabispidiinühendid, nende valmistamise meetod ning ravimvorm kasutamiseks südame arütmia raviks ja profülaktikaks | |
| EE200300504A (et) | 3,7-diasabitsüklo[3.3.1]preparaadid, nende valmistamise meetod ja nimetatud preparaatide kasutaminesüdame arütmiate profülaktikas või ravis | |
| EE04852B1 (et) | C-21 modifitseeritud epotioloonid, nende valmistamise meetod ning kasutamine ja ravimkoostise kasutamine vähkkasvajate või teiste proliferatiivsete haiguste ravimisel | |
| HK1061679A1 (en) | Phenylsulfonyl-1,3-dihydro-2h-indole-2-ibe derivatives, their preparation and their therapeutic use. | |
| EE04497B1 (et) | Püridopüranoasepiini derivaadid, nende valmistamine ja terapeutiline kasutamine | |
| NO20022021D0 (no) | Indeno-, nafto- og benzocyklohepta-dihydrotiazolderivater, fremstilling av de samme og deres anvendelse somanoreksilegemidler | |
| EE200300364A (et) | 3,7-diasabitsüklo[3,3,0]oktaanid ja nende kasutamine südame arütmiate ravis | |
| EE200200305A (et) | Südame arütmiate ravis kasutatavad uued asabitsüklooktaani derivaadid | |
| NO20020156D0 (no) | Titanavledede forbindelser, fremstilling og anvendelse derav | |
| EE200300495A (et) | 3,7-diasabitsüklo[3.3.1]preparaadid, nende valmistamise meetod ja nimetatud preparaatide kasutaminesüdame arütmiate profülaktikas või ravis | |
| MXPA03002679A (es) | Nuevo compuesto de oxabispidina util en el tratamiento de arritmias cardiacas. | |
| EE200300506A (et) | 3,7-diasabitsüklo[3.3.1]preparaadid, nende valmistamise meetod ja nimetatud preparaatide kasutaminesüdame arütmiate profülaktikas või ravis | |
| AU2001296173A1 (en) | 3,8-diazabicyclo(3.2.1)octanes and their use in the treatment of cardiac arrhythmias | |
| NO20042846L (no) | Derivater av 5-(pyridin-3-yl)-1-azabicyklo[3.2.1]oktan, fremstilling derav og anvendelse av de samme som terapeutiske midler | |
| IS2380B (is) | 3-Heteróarýl-3,5-díhýdró-4-oxó-4H-pýridasínó[4,5-b]indól-1-karboxamíð afleiður, framleiðsla þeirra og notkun þeirra við meðhöndlun | |
| IL153485A0 (en) | New bispidine compounds and their use in the treatment of cardiac arrhythmias | |
| AU2001292500A1 (en) | 1,2,5,10-tetrahydropyridazino(4,5-b)quinoline-1,10-diones and their use for the treatment of pain | |
| SI1360187T1 (en) | 3,7-diazabicyclo(3.3.0)octanes and their use in the treatment of cardiac arrhythmias | |
| FI990736A (fi) | Suoja- tai säilöntäainekoostumus, sen valmistusmenetelmä sekä sen käyttö | |
| ZA200109858B (en) | New bispidine compounds useful in the treatment of cardiac arrhythmias. | |
| AU2002214441A1 (en) | 1,2,5,10-tetrahydropyridazino(4,5-b)quinoline-1,10-diones and their use for the treatment of pain | |
| MXPA03004074A (es) | Derivados de retiferol y su uso en el tratamiento de enfermedades o trastornos de la piel asociadas con fotoda°o. | |
| HUP0300244A3 (en) | New bispidine compounds useful in the treatment of cardiac arrhythmias, process for their preparation, pharmaceutical compositions containing them and their use | |
| AUPQ790300A0 (en) | Diagnosis, prophylaxis and treatment of hepatitis C | |
| NO981460D0 (no) | Preparat for behandling og/eller profylakse av hudlidelser, samt anvendelse derav |